Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Role of oxidative stress in Retinitis pigmentosa: new involved pathways by an RNA-Seq analysis.

Donato L, Scimone C, Nicocia G, D'Angelo R, Sidoti A.

Cell Cycle. 2019 Jan;18(1):84-104. doi: 10.1080/15384101.2018.1558873. Epub 2018 Dec 28.

PMID:
30569795
2.

Correction to: Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride.

Catalano A, Martino G, Bellone F, Papalia M, Lasco C, Basile G, Sardella A, Nicocia G, Morabito N, Lasco A.

Clin Drug Investig. 2019 Jan;39(1):103. doi: 10.1007/s40261-018-0733-2.

PMID:
30478758
3.

Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride.

Catalano A, Martino G, Bellone F, Papalia M, Lasco C, Basile G, Sardella A, Nicocia G, Morabito N, Lasco A.

Clin Drug Investig. 2019 Jan;39(1):97-102. doi: 10.1007/s40261-018-0720-7. Erratum in: Clin Drug Investig. 2018 Nov 26;:.

PMID:
30367429
4.

GLO1 gene polymorphisms and their association with retinitis pigmentosa: a case-control study in a Sicilian population.

Donato L, Scimone C, Nicocia G, Denaro L, Robledo R, Sidoti A, D'Angelo R.

Mol Biol Rep. 2018 Oct;45(5):1349-1355. doi: 10.1007/s11033-018-4295-4. Epub 2018 Aug 11.

PMID:
30099685
5.

Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing?

Catalano A, ChilĂ  D, Bellone F, Nicocia G, Martino G, Loddo I, Morabito N, Benvenga S, Loddo S.

J Clin Transl Endocrinol. 2018 May 29;13:9-13. doi: 10.1016/j.jcte.2018.05.004. eCollection 2018 Sep.

6.

The combination of new missense mutation with [A(TA)7TAA] dinucleotide repeat in UGT1A1 gene promoter causes Gilbert's syndrome.

D'Angelo R, Rinaldi C, Donato L, Nicocia G, Sidoti A.

Ann Clin Lab Sci. 2015 Spring;45(2):202-5.

PMID:
25887876
7.

The future of phosphate binders: a perspective on novel therapeutics.

Cernaro V, Santoro D, Lucisano S, Nicocia G, Lacquaniti A, Buemi M.

Expert Opin Investig Drugs. 2014 Nov;23(11):1459-63. doi: 10.1517/13543784.2014.962652. Epub 2014 Sep 22.

PMID:
25243756
8.

Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients.

Bolignano D, Coppolino G, Romeo A, De Paola L, Buemi A, Lacquaniti A, Nicocia G, Lombardi L, Buemi M.

Nephrol Dial Transplant. 2009 Nov;24(11):3398-403. doi: 10.1093/ndt/gfp310. Epub 2009 Jun 23.

PMID:
19549696
9.

Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients.

Bolignano D, Lacquaniti A, Coppolino G, Donato V, Fazio MR, Nicocia G, Buemi M.

Kidney Blood Press Res. 2009;32(2):91-8. doi: 10.1159/000209379. Epub 2009 Mar 24.

10.

Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure.

Bolignano D, Basile G, Parisi P, Coppolino G, Nicocia G, Buemi M.

Rejuvenation Res. 2009 Feb;12(1):7-14. doi: 10.1089/rej.2008.0803.

PMID:
19196011
11.

Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.

Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio MR, Nicocia G, Buemi M.

Clin J Am Soc Nephrol. 2009 Feb;4(2):337-44. doi: 10.2215/CJN.03530708. Epub 2009 Jan 28.

12.

Effect of a single intravenous immunoglobulin infusion on neutrophil gelatinase-associated lipocalin levels in proteinuric patients with normal renal function.

Bolignano D, Coppolino G, Aloisi C, Romeo A, Nicocia G, Buemi M.

J Investig Med. 2008 Dec;56(8):997-1003. doi: 10.2310/JIM.0b013e31818e7e95.

PMID:
18955901
13.

Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin in macroproteinuric patients with worsening renal function.

Bolignano D, Coppolino G, Lacquaniti A, Nicocia G, Buemi M.

Kidney Blood Press Res. 2008;31(4):274-9. doi: 10.1159/000151665. Epub 2008 Aug 28.

14.

Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients.

Bolignano D, Coppolino G, Campo S, Aloisi C, Nicocia G, Frisina N, Buemi M.

Nephrol Dial Transplant. 2008 Jan;23(1):414-6. Epub 2007 Sep 24. No abstract available.

PMID:
17893105
15.

Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease.

Bolignano D, Coppolino G, Campo S, Aloisi C, Nicocia G, Frisina N, Buemi M.

Am J Nephrol. 2007;27(4):373-8. Epub 2007 Jun 13.

PMID:
17570904
16.

Adiponectin and insulin resistance in early- and late-onset pre-eclampsia.

D'Anna R, Baviera G, Corrado F, Giordano D, De Vivo A, Nicocia G, Di Benedetto A.

BJOG. 2006 Nov;113(11):1264-9. Epub 2006 Sep 27.

17.

Mild hyperhomocysteinemia and the common C677T polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes.

Russo GT, Di Benedetto A, Alessi E, Ientile R, Antico A, Nicocia G, La Scala R, Di Cesare E, Raimondo G, Cucinotta D.

J Endocrinol Invest. 2006 Mar;29(3):201-7.

PMID:
16682831
18.

Inflammatory markers in women with a recent history of gestational diabetes mellitus.

Di Benedetto A, Russo GT, Corrado F, Di Cesare E, Alessi E, Nicocia G, D'Anna R, Cucinotta D.

J Endocrinol Invest. 2005 Jan;28(1):34-8.

PMID:
15816369
19.

Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failure.

Zoccali C, Mallamaci F, Tripepi G, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Stancanelli B, Nicocia G, Buemi M.

J Intern Med. 2003 Aug;254(2):132-9.

20.

Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure.

Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Nicocia G, Buemi M.

Eur J Clin Invest. 2003 Jul;33(7):561-6.

PMID:
12814392
21.

Effects of atorvastatin treatment on sICAM-1 and plasma nitric oxide levels in hypercholesterolemic subjects.

Sardo MA, Castaldo M, Cinquegrani M, Bonaiuto M, Maesano A, Versace A, Spadaro M, Campo S, Nicocia G, Altavilla D, Saitta A.

Clin Appl Thromb Hemost. 2002 Jul;8(3):257-63.

PMID:
12361204
22.

Mitogen-activated protein kinases and NF-kappa B are involved in TNF-alpha responses to group B streptococci.

Mancuso G, Midiri A, Beninati C, Piraino G, Valenti A, Nicocia G, Teti D, Cook J, Teti G.

J Immunol. 2002 Aug 1;169(3):1401-9.

23.

The anti-tumor activity of bacillus Calmette-Guerin in bladder cancer is associated with an increase in the circulating level of interleukin-2.

Magno C, Melloni D, Galì A, Mucciardi G, Nicocia G, Morandi B, Melioli G, Ferlazzo G.

Immunol Lett. 2002 May 1;81(3):235-8.

PMID:
11947931
24.

Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.

Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y.

J Am Soc Nephrol. 2002 Jan;13(1):134-41.

25.

Pentosidine, carotid atherosclerosis and alterations in left ventricular geometry in hemodialysis patients.

Zoccali C, Mallamaci F, Asahia K, Benedetto FA, Tripepi G, Tripepi R, Nicocia G, Buemi M, Miyata T.

J Nephrol. 2001 Jul-Aug;14(4):293-8.

PMID:
11506253
26.

Polyamine metabolism in prostaglandin E2-treated human T lymphocytes.

Ruggeri P, Nicocia G, Venza I, Venza M, Valenti A, Teti D.

Immunopharmacol Immunotoxicol. 2000 Feb;22(1):117-29.

PMID:
10737261
27.

Resistance to PGE2 inhibition of PWM-stimulated lymphocytes from neoplastic patients.

Nicocia G, Garipoli C, Venza M, Venza I, Sottile A, Pitini V, Teti D.

Clin Immunol Immunopathol. 1998 May;87(2):115-23.

PMID:
9614925
28.

[Functional phenotypic immunological aspects in patients with LAS/ARC].

Resta ML, Santarpia G, Valenti A, Nicocia G, Serrao N, Berlinghieri G.

G Batteriol Virol Immunol. 1989 Jan-Dec;82(1-12):48-55. Italian.

PMID:
2490404

Supplemental Content

Loading ...
Support Center